𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: Implications for antifibrotic therapy

✍ Scribed by Yutaka Yata; Philip Gotwals; Victor Koteliansky; Don C. Rockey

Book ID
111721822
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
399 KB
Volume
35
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy by transforming growth fact
Gene therapy by transforming growth factor-beta (TGF-β) receptor-IGG FC chimera, soluble TGF-β receptor, suppresses dimethylnitrosamine-induced hepatic fibrosis in rats: Makoto Nakamuta, Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka Japan; Shusuke Morizono, Department of Medicine, Fukuoka City Hospital, Fukuoka Japan; Munechika Enjoji, Satoru Tsuruta, Marie Fukutomi, Masami Kuniyoshi, Takashi Irie, Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka Japan; Yuichi Tanabe, Department of Medicine, Fukuoka City Hospital, Fukuoka Japan; Hajime Nawata, Department of Medicine and Bioregulatory Science, Kyushu University, Fukuoka Japan
📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB